Conference Abstracts
TECHNICAL SESSIONS 1 to 3 - 11 APRIL 2017 Technical Session 1 - Industry 4.0 : Computerisation of Smart Manufacturing for the Future of Today
Introducing an auto-adaptive process control system that almost no one wanted Wes McConnell, CEO, Frameworxs Analytics, USA 12:40 – 13:00 The speaker introduces DaVinxi, a cloud-based, auto-adaptive process control strategy designed to allow tissue machines to produce consistent quality at the lowest cost, even under varying operating environments. Results can also be combined with quality and financial data to create actionable information. The author explains how this technical approach works, discusses the difficulties of implementing the system and how the team overcame these challenges. Finally, the author describes why almost no-one wanted this technology. However, over time, they all wanted it. DaVinxi is now in its next level of development
Industry 4.0 for direct data exchange between production, converting and consumer Giovacchino Giurlani, Head of Technology and FuturaLab, Futura , Italy 13:00 – 13:20 Industry 4.0 is about big data analysis and the way this information is communicated. What has this got to do with tissue converting? Until now, not so much. But change is here and Futura will explain how the important data which can be generated during tissue manufacturing can now be transmitted direct to the converting facility and vice-versa. It means that the converting line can respond automatically to the characteristics of the tissue paper which it processes. The tissue converting line can, in turn, report to downstream processes right to the point where the consumer picks the product off the shelf. Industry 4.0 seems like a big idea but in reality it is about the collective power of many small changes to affect significant improvements in Overall Equipment Effectiveness. Its impacts can be felt in terms of product quality, production efficiency, safety, maintenance routines – the list goes on. Futura presents actual examples of converting technologies developed at FuturaLab to make better use of data analysis. Futura will explain how the process of building intelligence into converting will have real-world effects: better process control, preventing avoidable stoppages and improving traceability, all with target of keeping the line running at best efficiency. It will enable tissue manufacturers to realise their Industry 4.0 ambitions – a goal already being realised in advanced tissue converting facilities.